The Nasdaq 100 has been hit incredibly hard. There's an intriguing contrarian case for not giving up on the group.

WASHINGTON, April 24, 2025 (GLOBE NEWSWIRE) -- Socially Determined, a social risk analytics and solutions company leading the integration of health and social care, and Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, have partnered to deliver the power of data, raw computing, and AI analytics to help state healthcare agencies more accurately predict and target interventions that improve health outcomes for individuals and communities, and reduce program costs. The partnership allows Acentra Health to leverage Socially Determined's nationwide access to …

Blachem (BCPC) came out with quarterly earnings of $1.22 per share, missing the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.89 per share a year ago.

First Bancorp (FBP) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.44 per share a year ago.

Fiserv (FI) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $2.08 per share. This compares to earnings of $1.88 per share a year ago.

Ameriprise Financial Services (AMP) came out with quarterly earnings of $9.50 per share, beating the Zacks Consensus Estimate of $9.12 per share. This compares to earnings of $8.39 per share a year ago.

Interpublic Group (IPG) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.36 per share a year ago.

NovoCure (NVCR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.36 per share a year ago.

First Northwest Bancorp (FNWB) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.04 per share a year ago.

PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to loss of $0.51 per share a year ago.

TriCo (TCBK) came out with quarterly earnings of $0.80 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.83 per share a year ago.

Valley National (VLY) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.19 per share a year ago.

Pool Corp. (POOL) came out with quarterly earnings of $1.32 per share, missing the Zacks Consensus Estimate of $1.42 per share. This compares to earnings of $1.85 per share a year ago.

West Bancorp (WTBA) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.35 per share a year ago.

Mobileye Global (MBLY) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate. This compares to loss of $0.07 per share a year ago.

Vanguard Information Technology Index Fund (VGT) is down 12% in the last month but has gained 3.5% over the last year. VGT is heavily weighted in Apple, Nvidia, and Microsoft, which account for nearly 50% of its holdings. Despite a 21% correction, VGT's valuation remains high with a P/E ratio of 33.2, but earnings growth is strong at 28.3%.

Impinj, Inc.'s strong results and guidance caused a 15% share price surge, but I remain cautious due to its 25x forward EBITDA and negative growth rates. Despite being debt-free, Impinj's valuation at 54x next year's EBITDA is unappealing, and I predict a challenging path back to $160 per share. Impinj's revenue growth is volatile and cyclical, with Q2 2025 guidance indicating further negative growth, making its 25x forward EBITDA valuation for PI stock hard to justify.

SHANGHAI , April 24, 2025 /PRNewswire/ -- Dear Shareholders, On behalf of Noah's Board of Directors (the "Board") and management team, I would like to extend our sincerest gratitude to all shareholders. The year 2024 marked a pivotal chapter in our global expansion, representing a new era of entrepreneurship for Noah.

Shares of Merck & Co. were headed higher in early Thursday trading, after the drugmaker extended its long streak of quarterly earnings beats and held firm with its full-year outlook despite expected tariff costs.

American Express shows strong financial performance with 7% YoY revenue growth, 6% net income growth, and 9% diluted EPS growth, justifying its 18x P/E ratio. Consistent mid-to-high single-digit growth in billed business and double-digit growth in international card services highlight the company's robust business model. Solid credit metrics with a 1.3% 30+ days past due rate and 2.1% net write-off rate in a high-interest environment are impressive.